HOME MARKET NEWS CENTRE IPO ABOUT US Research Stock-Screener 04 May, 2024 16:46 IST Get Quote Snapshot Charts Financials Research News

my Last 5 Scrips Company BSE Price(Rs) % Chg Yes Bank 24.08 42.49 Tata Stl 136.20 30.33 Ong Corp 256.00 95.64 I T C Lt 438.65 28.62 Ntpc Ltd 319.00 89.15 Clear All Clear Last Equity NSE Live Nifty Live Prices Top Gainers/Losers Top 10 Turnover BSE Live BSE30 Live Prices Top Gainers/Losers Top 10 Turnover Market Pulse Leaders Laggards FII Activity Results Watch Results Calendar Results Announced IPO Watch Company Quotes Charts Financials Recent News Broker Research Research Research Reports	Bafna Pharmaceuticals Limited Pharmaceuticals - Bulk Drugs and Formulations BSE:532989 NSE:BAFNAPH Bloomberg:BFNA@IN Reuters:BAFP.BO Market Lot: 1 Face Value: 10 ISIN Demat: INE878I01022 Quotes Charts Financials Research Recent News MF Holding BSE/NSE Notices Company Announcements Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11-JAN-24 Closure of Trading Window 29-DEC-23 Discrepancies In Financial Results. 09-DEC-23 Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances 08-DEC-23 Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances 07-DEC-23 Announcement under Regulation 30 (LODR)-Newspaper Publication 10-NOV-23 Financial Results For The Quarter And Half Year Ended September 2023. 10-NOV-23 Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For The II Quarter And Half Year Ended September 30, 2023, For The FY 2023-24. 09-NOV-23 Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors - Approval Of Q2 FY24 Financial Results. 30-OCT-23 Submission Of Certificate By RTA In Compliance Of Regulation 74(5) Of SEBI (Depository & Participants) Regulations, 2018, For The Quarter Ended September 30, 2023.\r\n 09-OCT-23 Statement Of Investor Complaints - Quarter Ended September 30, 2023.\r\n\r\n 04-OCT-23 Closure of Trading Window 29-SEP-23

© All rights reserved. IRIS Business Services Limited Disclaimer